Pulvinar Neuro specializes in the development of innovative brain stimulation devices aimed at advancing research in dynamic brain stimulation. Their initial focus was on creating user-friendly transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS) devices designed for rigorous double-blind studies. The company is committed to ongoing research and product development, with plans to launch the XCSITE-RD in Fall 2024. This new non-invasive brain stimulation solution will enhance research capabilities by delivering high-powered tACS, tDCS, and custom waveform stimulation, all while being compliant with investigational use regulations in the United States and EU.

The first-generation device, XCSITE 100, was specifically engineered for high-quality double-blind tDCS/tACS studies, addressing the need for reliable and effective research tools. Although Pulvinar Neuro has ceased sales of the XCSITE 100, they continue to support existing users. The device is noted for its ease of use, featuring a one-button operation and a user-friendly app, making it accessible even for novice research assistants. The XCSITE 100 has been utilized in multiple peer-reviewed publications across various medical indications, demonstrating its effectiveness in studies related to major depressive disorder, chronic pain, and substance use disorders.

United States

We're a small but rapidly growing neurotechnology company based in Durham, North Carolina.

Our vision is to enable and support outstanding basic and translational neuroscience research through innovative and affordable products. We launched XCSITE 100, our tDCS/tACS research solution, in 2016. Today, XCSITE 100 is used in leading brain stimulation labs across the United States. We are actively developing new technology and working with our stakeholders to provide new research solutions to enable cutting edge neuroscience.

Pulvinar Neuro

Company Details